International Top-Tier Journal Study Sounds Alarm on Dementia Prevention and Treatment Integrated Approach to "Prevention, Screening, Diagnosis, Treatment, and Care" Faces Challenges
In January 2026, a landmark study by a Chinese research team published in the top-tier international journal International Journal of Nursing Studies sounded another alarm for dementia prevention and control efforts in China. This long-term cohort study spanning 1990 to 2023 compiled health data from 680,000 Chinese adults aged 60 and older. It produced China's first comprehensive dementia prevalence map, clearly revealing the epidemic trends and regional distribution patterns of dementia in the country.
Research data vividly illustrates the severity and complexity of dementia prevalence in China. Statistics reveal that the overall prevalence rate of dementia among individuals aged 60 and above reaches 4.76%, indicating that approximately 5 out of every 100 elderly individuals suffer from dementia. Moreover, this prevalence rate continues to rise, placing significant strain on the nation's elderly care and healthcare systems.
What is even more noteworthy is the significant regional disparity in dementia prevalence across China. Despite sharing the same country, the risk of developing dementia among elderly individuals varies by up to 14-fold across different provinces. This regional distribution not only reflects the correlation between dementia prevention and control efforts, economic development levels, and healthcare resource allocation, but also underscores the urgent need to establish a comprehensive, equitable, and accessible prevention and treatment system nationwide.
Meanwhile, the early-stage dementia diagnosis rate in China stands at only 28.6%, with the rate for mild dementia as low as 2.8%. A staggering 95% of patients are diagnosed at the moderate-to-late stages, significantly increasing the caregiving burden on families and society. This underscores the critical necessity and urgency of "early detection, early intervention, and early treatment" in dementia prevention and management.
Facing this severe situation, Huisi Anpu leverages its accumulated expertise in biomedical technology. Supported by five core technologies-bioelectrical impedance, bionic pulse magnetic resonance, brain-computer interfaces, neuromodulation, and artificial intelligence-it has innovatively established a closed-loop model covering the entire spectrum of "prevention, screening, diagnosis, treatment, and care." This model shifts the focus of prevention and treatment to earlier stages, achieving comprehensive coverage from early prevention to lifelong wellness and rehabilitation. It precisely addresses the limitations of traditional prevention and treatment models, which are often fragmented, lack precision, and have limited coverage. diagnosis, treatment, and care. This closed-loop model shifts the focus of prevention and treatment to earlier stages, achieving comprehensive coverage from early prevention to full-cycle wellness management. It precisely addresses the pain points of traditional prevention and treatment models, such as fragmentation, low precision, and limited coverage.
In the prevention phase, HSAP focuses on targeted public science education as its core strategy to establish the first line of defense through early awareness. The company collaborates deeply with the China Health Promotion Foundation, upholding the principle of "early awareness, early intervention, early benefits." It systematically disseminates knowledge about early warning signs of dementia, high-risk triggers, and scientific prevention methods to seniors, their families, and the broader public, with a particular focus on dispelling the misconception that "senile forgetfulness is a normal part of aging." Through its "Four-Pronged Outreach" initiative-extending science education into communities, households, elderly care facilities, and medical institutions-the company actively promotes healthy lifestyles featuring regular routines, balanced nutrition, and moderate cognitive training. This approach reduces cognitive decline risks at their source, laying a solid societal foundation for cognitive health.
Screening diagnosis serves as the critical entry point for the closed-loop model. HSAP innovatively developed a multimodal precision detection model integrating artificial intelligence, authoritative scales, and electroencephalography (EEG), enabling large-scale screening diagnosis that is cost-effective, highly efficient, and broadly accessible.
Addressing the challenges of insufficient grassroots screening resources and the subjective limitations of traditional assessment scales, the ADDS Cognitive Impairment Screening System employs non-invasive brain-computer interface technology. Through human-computer interaction, it dynamically collects EEG signals and utilizes AI algorithms to extract characteristic parameters such as alpha and beta waves for in-depth analysis. This enables rapid and precise differentiation between cognitively normal individuals, those with mild cognitive impairment, and those at risk of dementia. Scientific test results are generated in approximately 15 minutes, providing robust support for developing personalized intervention plans. This advances dementia diagnosis from "exclusionary diagnosis" to "precision diagnosis."
Addressing dementia's clinical principle of "incurable but effectively delayable," Huisi Anpu has established a non-invasive, safe, and targeted intervention system centered on brain-computer interface core technology. The ADTS Memory Impairment Training System enables users to control rehabilitation game progress through thought, comprehensively enhancing patients' attention, memory, calculation, and other multidimensional cognitive functions.
The ADMS Cognitive Neuromodulation System employs combined sensory stimulation through visual, auditory, and tactile inputs. By integrating photobiomodulation of specific brain regions with ultra-low-frequency whole-body magnetic field stimulation, it induces broader and more potent gamma oscillations across multiple dementia-related brain areas-including the hippocampus, insula, and amygdala-effectively alleviating neurodegenerative lesions and dementia symptoms in patients.
Following the treatment phase, the ADDS cognitive impairment screening system enables precise evaluation of training intervention outcomes, allowing for dynamic optimization of intervention plans. This addresses the shortcomings of traditional rehabilitation training, which often lacks targeting and yields ambiguous results.
In the "nurturing" phase, HSAP establishes a seamless, full-cycle wellness system integrating diagnosis, treatment, and care. Through multi-device collaboration, it delivers personalized, comprehensive wellness support for dementia patients and high-risk cognitive individuals.
The core device matrix includes:
- HRA Health Risk Assessment utilizing bioimpedance technology, which non-invasively evaluates 220 functional indicators across nine major body systems in just 5 minutes and 38 seconds, comprehensively screening for health risks; PMR Microcirculation Repair, utilizing bionic pulsed magnetic resonance technology, enhances cerebral blood and oxygen supply while restoring microcirculatory impairments; EIS/ERS Cellular Function Regulation precisely screens and intervenes in red blood cell aggregation states, boosting oxygen-carrying capacity at the cellular level; SMIS Pulsed Magnetic Sleep Therapy modulates the nervous system through ultra-low-frequency pulsed magnetic fields, optimizing sleep quality to support brain function restoration.
Multiple technologies and devices collaborate to form a complete rehabilitation and wellness closed-loop system encompassing "assessment-rehabilitation-regulation-maintenance," truly achieving "care for the sick with effective outcomes."
Currently, the HSAP full-chain closed-loop model has established an application network covering diverse medical scenarios across China. In tertiary hospitals, it provides precise data support for personalized treatment of complex cases; in community health service centers, it facilitates early screening and tiered interventions; in county-level primary care facilities, it bridges the gap in early screening technology for cognitive impairment through technology deployment, extending early screening and diagnosis to grassroots levels and effectively alleviating the uneven distribution of medical resources.
This model not only offers an efficient and viable solution for addressing dementia prevalence in China but also contributes "Chinese wisdom" to global dementia prevention and control through original technological prowess. It injects powerful momentum into fortifying the cognitive health defenses for hundreds of millions of elderly citizens and advancing the high-quality development of aging care and wellness services.